Pulmonx (LUNG) Non-Current Deferred Tax Liability (2019 - 2025)
Pulmonx (LUNG) posted quarterly Non-Current Deferred Tax Liability of $69000.0 for Q4 2025, down 20.69% year-over-year from $87000.0 in Q4 2024, and up 46.81% quarter-over-quarter from $47000.0 in Q3 2025.
Pulmonx (LUNG) Non-Current Deferred Tax Liability (2019 - 2025) Analysis & Trends
Pulmonx (LUNG) has reported Non-Current Deferred Tax Liability for 7 consecutive years, with $69000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Non-Current Deferred Tax Liability fell 20.69% year-over-year to $69000.0; the TTM figure through Dec 2025 stood at $69000.0 (down 20.69% YoY), while the FY2025 annual figure was $69000.0, down 20.69% from the prior year.
- Non-Current Deferred Tax Liability rose to $69000.0 in Q4 2025 per LUNG's latest filing, from $47000.0 in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $1.3 million in Q4 2023 and bottomed at $37000.0 in Q4 2021.
- Historically, Non-Current Deferred Tax Liability has averaged $137500.0 across 5 years, with a median of $71000.0 in 2021.
- Annual changes were most pronounced in 2023 — Non-Current Deferred Tax Liability surged 1265.96% — and 2024, when it sank 93.22%.
- Pulmonx's Non-Current Deferred Tax Liability stood at $37000.0 in 2021, then surged by 154.05% to $94000.0 in 2022, then soared by 1265.96% to $1.3 million in 2023, then tumbled by 93.22% to $87000.0 in 2024, then declined by 20.69% to $69000.0 in 2025.
- Business Quant data shows LUNG's Non-Current Deferred Tax Liability at $69000.0 in Q4 2025, $47000.0 in Q3 2025, and $41000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Pulmonx | 93.95 Mn | 24.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 69,000.00 |
| Dec 31, 2025 | 69,000.00 |
| Sep 30, 2025 | 47,000.00 |
| Sep 30, 2025 | 47,000.00 |
| Jun 30, 2025 | 41,000.00 |
| Jun 30, 2025 | 41,000.00 |
| Mar 31, 2025 | 79,000.00 |
| Mar 31, 2025 | 79,000.00 |
| Dec 31, 2024 | 87,000.00 |
| Dec 31, 2024 | 87,000.00 |
| Sep 30, 2024 | 129,000.00 |
| Sep 30, 2024 | 129,000.00 |
| Jun 30, 2024 | 118,000.00 |
| Jun 30, 2024 | 118,000.00 |
| Mar 31, 2024 | 140,000.00 |
| Mar 31, 2024 | 140,000.00 |
| Dec 31, 2023 | 1.28 Mn |
| Dec 31, 2023 | 1.28 Mn |
| Sep 30, 2023 | 97,000.00 |
| Sep 30, 2023 | 97,000.00 |